Research Funding Gaps Revealed Treatment Action Group has published two new reports on the crisis in national and international funding for scientific research on AIDS, tuberculosis (TB), and viral hepatitis. TB and hepatitis are diseases that affect hundreds of millions…
Hepatitis C Treatment, Psychiatric Medications (SSRIs), Growth Factors, Hepatitis Vaccines (March 2009) Hepatitis C virus (HCV) is a common and serious comorbidity among HIVpositive people in the United States; up to 30%—approximately 332,000— are living with HCV. Hepatitis C can…
Research presentation poster by Tracy Swan and Lei Chou; winner of a Chairman’s Choice Award at the 2008 HIV DART conference “Frontiers in Drug Development for Antiretroviral Therapies.” The complete text is available online. Populations in Preapproval Studies and…
Outbreaks of sexually transmitted hepatitis C infection have been reported among HIV-positive gay men. Early diagnosis and treatment can prevent serious liver disease, but too few doctors notice the warning signs. BY Tracy Swan A new epidemic of hepatitis…
Recommendations submitted by Treatment Action Group to President Barack Obama on ways to strengthen the struggle to end AIDS Demonstrate Strong Domestic and Global Leadership TAG urges President Obama to make fighting AIDS a national and global priority through…
Making Treatment Decisions in an Evidence-Free Zone By Lei Chou New drug development; treatment strategies; natural history; long-term outcomes: The lack of support for research on hepatitis B virus is putting millions of people with the virus at risk. People…
New Surveillance Networks Needed By Tracy Swan Recent outbreaks of acute hepatitis C virus (HCV) among HIV-positive men who have sex with men (MSM) have been reported in England, France, Germany, Holland, and the United States. Many of these cases…
In March 2007, a group of community activists, many living with HIV and hepatitis C virus (HCV), gathered with researchers, doctors, regulators, and representatives from Abbott, Roche, Schering, and Tibotec, in Sitges, Spain, at a meeting held by the European…
Excerpts from the FDA Hearings By Bob Huff There are a large number of experimental drugs now being developed to treat hepatitis C virus (HCV) infection. A race is on to find new HCV drugs because millions of people may…
Growing Chasm Between Bench and Bedside By Tracy Swan Hepatitis C virus (HCV) and HIV/HCV coinfection were prominently featured at this year's Retrovirus conference. Coverage ranged from scientific progress in the laboratory to treatment access in the clinic. During the…